THCB

Categories

Above the Fold

“Going Digital: Behavioral Health Tech Conference” Matthew Holt & Jessica DaMassa’s Long, Exhaustive & Boring Overview

• 1

Matthew Holt and Jessica DaMassa gave a talk at the “Going Digital: Behavioral Health Tech Conference” on June 17, 2020. They spoke about how technology is evolving the mental health space, along with their thoughts on where the future of the industry is headed.

Jess & Matthew first start off with their “Health in 2 Point 00” segment, discussing all of the funding deals in the mental health space, from Headspace to Mindstrong raising money in Q1, to Kaiser rolling out MyStrength to its members.

Then they jump into a deeper dive segment, where they discuss how the money is being distributed in the mental health space, and how startups are coming up with creative solutions to package their services. Some mental health companies are wrapping solutions into other digital health platforms that already manage chronic conditions, like Livongo & Omada, others are working to directly address and treat mental health issues, and some are developing digital therapeutic solutions to manage mental health problems. As this part of the industry grows, Matthew & Jess predict how the mental health tech space will change & develop with increasing demand, more investments, and a lot more innovative tools to serve the population’s needs.

Zoya Khan is the EIC of The Health Care Blog & a Strategy Manager at SMACK.health

Repurposing a Universally Installed EHR App Into an Effective COVID-19 Early Detection System

• 1

By SCOTT WEINGARTEN, MD

COVID-19 exposed our country’s lack of centralized coordination when it comes to managing and preventing disease spread. Today, our public health system relies on flawed data and obsolete technology that fails to accurately track current and suspected cases, risk stratify patients, monitor disease progression or predict future spread. Not only do these blind spots create opportunities for the disease to spread, they also undermine the ability to safely plan for economic recovery.

What may surprise some, though, is the fact that we don’t have to start from scratch in order to build an effective system that stems the spread of COVID-19. In large part, the infrastructure we need is already here.

In 2009, Congress passed the HITECH Act, which allocated roughly $30 billion for providers to purchase electronic health records (EHRs). As a result of this stimulus, EHRs went from relative obscurity to ubiquity, and today about 96 percent of all providers are users of EHRs. Five years later, Congress passed the Protecting Access to Medicare Act (PAMA), which requires healthcare providers to consult with an approved Clinical Decision Support Mechanism (CDSM) in order to receive reimbursement for advanced imaging procedures for Medicare beneficiaries. 

The net result of these two laws is that there is now visibility into nearly every patient-provider interaction in the United States at the moment that care is delivered, through more than a dozen CDSMs that have been certified by CMS. Although PAMA was intended for use with imaging, it’s not difficult to add on and repurpose decision support apps to conduct symptom surveillance for COVID, enabling healthcare workers to spot cases more reliably and earlier in the disease progression for prompt action.

Continue reading…

Health in 2 Point 00, Episode 136 | Telepharmacy, a Mega-Merger, & DoorDash’s Deal with Walgreens

On Episode 136 of Health in 2 Point 00, Jess has 15 new deals to talk about (and its only been a day since the last episode!). Jess asks me about CityBlock getting $54M for their Series B round to provide primary care services to dual-eligible Medicare and Medicaid members in New York, Medly raising $100M & NowRx crowdsourcing $20M to grow their telepharmacy platforms, the mega-merger of Curavi, Carepointe, and U.S. Health Systems (now called Arkos Health) to develop out a care coordination platform, and DoorDash partnering with Walgreen to distribute non-prescription drugs. —Matthew Holt

Everyone has a role to play: Reducing your child’s risk of developing food allergies

• 2

By RUCHI GUPTA, MD, MPH

The average American elementary school class includes two students living with one or multiple food allergies. That’s nearly six million children in the United States alone. And these numbers are climbing. There was a staggering 377 percent increase in medical claims with diagnoses of anaphylactic food reactions between 2007 and 2016, two-thirds of these were children.

As parents, we want the absolute best for our children. For many years, guidance around food introduction was unclear. Parents were told that babies, and especially those considered at risk for food allergies, should avoid some allergy-causing foods such as peanuts until they were three years old.

But thanks to ongoing research from our nation’s top allergists and immunologists, we are beginning to learn more and more about food allergies, including what new and expecting parents can do to reduce the risk of their children developing food allergies. In fact, studies now show that introducing a variety of foods early is the best course of action and has been shown to reduce the occurrence of certain food allergies like peanuts for many children.

For instance, the partially FARE-funded Learning Early About Peanut Allergy (LEAP) study showed a remarkable 80 percent reduction in peanut food allergies in high-risk infants who were exposed to peanut foods at a young age. Shortly after LEAP, there was the Enquiring About Tolerance, or EAT, study. This project, led by top medical researchers at Kings College London, found significant reductions in allergies to both peanut and egg after introducing small amounts of the foods into infants’ diets. The LEAP-on study soon followed, and had the same children from the original LEAP study remove peanut from their diets for 12-months. The results showed that they maintained their tolerance to peanut, indicating early introduction to babies can result in long-lasting protection from peanut allergy.

Continue reading…

THCB Gang, Episode 18 LIVE 7/16 from 1PM PT/4PM ET

Episode 18 of “The THCB Gang” was live-streamed on Thursday, July 16tth! Watch it below.

Joining Matthew Holt were some of our regulars: writer Kim Bellard (@kimbbellard), policy & tech expert Vince Kuraitis (@VinceKuraitis), MD turned leadership coach Maggi Cary (@MargaretCaryMD), and guest Suneel Ratan, GM of Collective Medical Technologies (@CollectiveMed)! We discussed ACOs & fee-for-service problems, what the future of care looks like as a result of the November elections, and how to serve communities that are socioeconomically disadvantaged with calls to #DEFUNDHealthcare. Give it a watch below if you missed the live version

If you’d rather listen, the audio is preserved as a weekly podcast available on our iTunes & Spotify channels — Zoya Khan

The Trump COVID Legacy: Bad Timing. Lots of Questions. Few Answers.

• 2

By MIKE MAGEE, MD

What a strange irony. Trump decides, full-bravado, to challenge China to a trade war just months before China unwittingly hatches a virulent pandemic that collapses our deeply segmented health care system and our economy simultaneously. And rather than cry “Uncle”, our President then fires the WHO just as their experts are heading to China to attempt to unravel the mystery of COVID-19.

With the ongoing, cascading catastrophe of Trump’s mishandling of COVID-19, it is easy to lose sight that the next pandemic (fueled by global warming, global trade, and human and animal migration) is just around the corner. And we haven’t even begun to nail down the origin story of this one.

Unraveling the transmission trail requires international cooperation. As one expert recently noted, “Origin riddles for other new infectious diseases often took years to solve, and the route to answers has involved wrong turns, surprising twists, technological advances, lawsuits, allegations of cover-ups, and high-level politics.”

What we do know is that there are originators, intermediate hosts, and human super-spreaders….and COVID-19 appears to have begun in China.  These are not new insights. We’ve seen this playbook before.

Continue reading…

Health in 2 Point 00, Episode 135 | Amazon’s primary care entry, UnitedHealth’s digital DPP & more

• 1

Today on Health in 2 Point 00, it’s the 4th shoe! On Episode 135, we’ve got Amazon’s entry into primary care through its pilot program with Crossover Health, UnitedHealth Group launching Level2, their own digital health diabetes prevention program, Health Catalyst acquiring healthfinch, Truepill raising $25 million and then investing in Ahead, a company which matches psychiatrists to patients. —Matthew Holt

The 2020 Pandemic Election

The 2020 US election will be vicious, with a nasty pandemonium following a nasty pandemic.

By SAURABH JHA, MD

When the COVID-19 pandemic is dissected in the 2020 presidential election debates, Donald Trump will be at a disadvantage. The coronavirus has killed over 100,000 Americans and maimed thousands more. The caveat is that deaths per capita, rather than total deaths, better measure national failure, and by that metric the US fares better than Belgium, Italy and the United Kingdom. New York City owns a disproportionate share of the deaths, but this hyperconnected megapolis is an outlier whose misfortunes can’t be used to draw conclusions about administrative competence for the country as a whole.

Nevertheless, even after introducing nuance, the numbers aren’t flattering. President Donald Trump may claim that the US dodged the calamity predicted by the epidemiological models, which foretold millions of deaths. To be fair, we don’t know the counterfactual — Jeremiads aren’t verifiable. The paradox of successful mitigation is that we can’t see the future we dodged, precisely because we avoided it.

Reducing the death count logarithmically, rather than merely arithmetically, won’t be celebrated because as bad as the worst case scenario could have been, the situation still looks awfully bad. Many still disbelieve the high death toll predicted by epidemiologists early on, particularly Trump supporters who believe the response to the virus, specifically the economic shutdown, has been criminally disproportionate. One can’t simultaneously believe that COVID-19 is no more dangerous than the seasonal flu and that Trump saved millions from the coronavirus. The constituency that acknowledges the lethality of COVID-19 and credits Trump for decisive action against it is small.

Triangle of Incompetence

Trump’s challenger, former Vice President Joe Biden, will charge that fewer Americans would have died had the Trump administration acted earlier. Trump may be accused of having blood on his hands, but such rhetoric is unnecessary. Biden’s team can simply show a montage of Trump’s bombast where he downplayed COVID-19’s lethality, dismissed doctors’ concerns about the shortage of personal protective equipment or exaggerated how well the US was containing the pandemic. Incidentally, the most iconic picture of the administration’s scornful indifference is the current vice president, Michael Pence, visiting a hospital without a mask, surrounded by health-care workers wearing masks.

Continue reading…

Health in 2 Point 00, Episode 134 | Health Tech’s “PPP Blacklist”, Walgreens and VillageMD, & more

Today on Episode 134 of Health in 2 Point 00, Jess and I cover Livongo’s stock price swinging, Brian Dolan’s PPP “Black List” for Health Tech Startups, and Oak Street Health & GoHealth filing their S-1’s. We also get Matthew’s take on Walgreen’s deal with Village MD to become a primary care center, and Doctor on Demand closing a $75M round, bringing its total to $235M in funding —Matthew Holt

Virtually Better

By KIM BELLARD

The COVID-19 pandemic couldn’t have come at a better time for virtual reality.  It has caused many workers to work remotely, introducing many workers to collaborative tools like Slack or Microsoft Teams and even more to video platforms like Zoom or Skype.  But we’re just beginning to understand what collaboration could look like — such as virtual reality (VR).

As CNBC noted: “Virtual reality is booming in the workplace amid the pandemic.”  Even a pre-pandemic Perkins Coie survey, done for the XR Association, predicted an explosion of immersive technologies like VR, augmented reality (AR), and mixed reality (MR).   Elizabeth Hyman, President of XRA, said: “We are at the precipice of an integration of XR technology that will transform businesses and society for the better.”  

The report expected healthcare to be the industry most impacted by immersive technologies (outside of gaming/entertainment).

Take VR-start-up Spatial, which thinks it has a better mousetrap.  Chief Product Officer described their solution to MIT News:

Spatial is a collaborative, holographic, augmented reality solution.  You can teleport to someone’s space, work as an avatar sharing that 3D space, and use it instead of a screen to manage a project, present an idea, and more.

Don’t you love the “and more,” as though the teleportation wasn’t enough?  

Continue reading…
assetto corsa mods